Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide (Q45254181)
scientific article published on September 1, 1992
Language:
Current Data About Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide
(P31) (Q13442814)
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

(P50) (Q61987523)
(P1545) 5
(P1932) L. C. Rovati
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

(P304) 1525-1528
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

(P407) (Q1860)

(P433) 9
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

(P478) 13
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

(P577) Tuesday, September 1, 1992
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

(P921) (Q60315441)
(P887)

(P1433) (Q326022)
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

(P1476) "Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide" (language: en)
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

(P2093) van Garderen-Hoetmer A
(P1545) 3
(P248)
(P698) 1394835
(P813) Monday, December 11, 2017

M. Meijers
(P1545) 1
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

M. J. Appel
(P1545) 2
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

A. van Garderen-Hoetmer
(P1545) 3
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

C. B. Lamers
(P1545) 4
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

J. B. Jansen
(P1545) 6
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

R. A. Woutersen
(P1545) 7
(P248)
(P698) 1394835
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1394835
(P813) Thursday, September 22, 2022

other details
description scientific article published on September 1, 1992

External Links
(P356) 10.1093/CARCIN/13.9.1525
(P698) 1394835